Revelation Biosciences, Inc. REVB
4.38 USD +0.02 (+0.46%)
At closeNov 12, 2026, 4:00 PM EST
4.36 -0.02 -0.46%
After hours · Nov 12, 4:00 PM ET
4.15 Day range 4.40
3.08 52-week range 40.60
- YTD
- +36.87%
- 1 year
- +11.45%
News
benzinga.com Revelation Biosciences Q3 EPS $(5.92) Beats $(6.16) Estimate Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(5.92) per share which beat the analyst consensus estimate of $(6.16) by 3.9 percent. This is a 88.04 percent increase over losses…
benzinga.com Revelation Biosciences Announces 1-For-7 Reverse Stock Split, Effective Oct. 20 Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, announced today
